Information Journal Paper
APA:
CopyMAYERS, M., SYMMANS, W.F., STEC, J., DAMOKOSH, A.I., CLARK, E., & HESS, K.. (2004). GENE EXPRESSION PROFILES PREDICT COMPLETE PATHOLOGIC RESPONSE TO NEOADJUVANT PACLITAXEL AND FLUOROURACIL, DOXORUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN BREAST CANCER. JOURNAL OF CLINICAL ONCOLOGY, 22(12), 2284-2293. SID. https://sid.ir/paper/555636/en
Vancouver:
CopyMAYERS M., SYMMANS W.F., STEC J., DAMOKOSH A.I., CLARK E., HESS K.. GENE EXPRESSION PROFILES PREDICT COMPLETE PATHOLOGIC RESPONSE TO NEOADJUVANT PACLITAXEL AND FLUOROURACIL, DOXORUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN BREAST CANCER. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2004;22(12):2284-2293. Available from: https://sid.ir/paper/555636/en
IEEE:
CopyM. MAYERS, W.F. SYMMANS, J. STEC, A.I. DAMOKOSH, E. CLARK, and K. HESS, “GENE EXPRESSION PROFILES PREDICT COMPLETE PATHOLOGIC RESPONSE TO NEOADJUVANT PACLITAXEL AND FLUOROURACIL, DOXORUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN BREAST CANCER,” JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 12, pp. 2284–2293, 2004, [Online]. Available: https://sid.ir/paper/555636/en